CAITLIN SCHOEN: Open Payments
NPI 1821484973 · COLUMBIA CITY, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$54 in 3 payments from 3 companies in 2025. Trend: 2023 $0 · 2024 $13 · 2025 $54
Food & beverage: $54
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 1 | $20 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
Products named: Veozah, CAPLYTA, AIRSUPRA.
Industry payments across IN — which companies pay providers there.
